Researchers discovered a rapid muscle self-repair mechanism that relies on the rearrangement of muscle fibre nuclei, independently of muscle stem cells. This process occurs rapidly after physiological damage or exercise-induced injury and represents a time- and energy-efficient protective mechanism for minor lesions.
A multidisciplinary team developed a method for identifying 3-dimensional features of scar tissue after myocardial infarction, enhancing cardiac magnetic resonance imaging's prognostic potential. The new method reveals significant correlation between low scar transmurality and ventricular tachycardia episodes, improving clinical practice.
Researchers at CNIC have identified a new mechanism involved in the regulation of cardiac hypertrophy, which may spur the development of new tools for its treatment. The SRSF4-GAS5-glucocorticoid receptor axis plays a crucial role in regulating ventricular function and preventing excessive heart muscle growth.
A study by researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III found that metoprolol significantly reduced lung infiltration and improved oxygenation in severely ill COVID-19 patients. The treatment also led to a shorter stay in the ICU and fewer days on mechanical ventilation.
The RESILIENCE project seeks to prevent anthracycline-induced cardiotoxicity in cancer patients through remote ischaemic preconditioning, with over 600 patients enrolled in a randomised clinical trial. Cardiac function will be evaluated using state-of-the-art cardiac magnetic resonance imaging.
Researchers found that mutations in cardiac myosin-binding protein C (cMyBP-C) cause HCM through unknown mechanisms, altering protein integrity or mechanical properties. This knowledge is crucial for clinical follow-up and treatment of patients and their families.
The study reveals that Meis transcription factors are crucial for the formation and antero-posterior patterning of limbs. Genetic deletion of all four family members showed that these proteins are essential for limb development.
A study by CNIC scientists found that glycosylated hemoglobin can identify individuals with advanced atherosclerotic disease and increased cardiovascular risk. The test can be used to calculate the degree of subclinical atherosclerosis in the general population, enabling personalized treatment plans.
Researchers at CNIC have discovered a specific blood marker for myocarditis, allowing clinicians to distinguish the disease from other cardiomyopathies. The biomarker, miR-721, was validated in numerous hospitals and has high sensitivity and specificity (>90%) for myocarditis diagnosis.
Scientists have discovered that the nitric oxide pathway is overactivated in Marfan Syndrome and causes aortic aneurysms. Inhibiting this pathway completely reverses the disease in a mouse model. The study identifies new therapeutic targets and markers for monitoring disease status.
Researchers found that high blood pressure alters artery structure, facilitating atherosclerosis development and increasing accumulation of LDL cholesterol in human-like arteries. Keeping both LDL cholesterol and blood pressure low is crucial for preventing atherosclerosis.
A study published in JACC reveals that clonal hematopoiesis, a phenomenon where acquired DNA mutations accelerate heart failure progression, is an independent risk factor. The presence of specific mutant clones, including those with TET2 and DNMT3A mutations, increases the risk of hospitalization and death from heart failure.
Researchers found a link between elevated cardiovascular risk and low brain metabolism in middle-aged individuals, with hypertension being the most closely associated factor. Atherosclerosis was also linked to lower brain metabolism, particularly in areas implicated in Alzheimer's disease.
Dendritic cells, key immune responders, can reprogram their genes to enhance immune response by changing epigenetic marks on DNA. This new mechanism could lead to improved vaccination and immunotherapy strategies.
Researchers at CNIC have identified a novel cellular and molecular mechanism that promotes vascular arterialization, enabling the development of arteries from blood capillaries. This breakthrough has significant implications for treating cardiovascular diseases, including coronary artery disease and myocardial infarction.
Researchers at CNIC have identified mitochondrial protein ALDH4A1 as a potential marker for cardiovascular disease diagnosis and a possible therapeutic target. The study found that ALDH4A1 accumulates in plaques and its plasma concentration is elevated in patients with carotid atherosclerosis, suggesting it as a biomarker.
Researchers at CNIC found that neutrophils acquire new characteristics when they arrive in a tissue and aid in maintaining organ health. This discovery suggests possible new treatments for diseases, including cancer, by leveraging the immune system's plasticity.
Researchers have identified a novel immune defence mechanism orchestrated by lipid droplets that attracts and eliminates invading pathogens, providing a broad-spectrum response. This strategy could be used to develop new therapeutic approaches in the era of antibiotic resistance.
A study has overcome a key hurdle to the use of nanorobots powered by lipases, enzymes that play essential roles in digestion. By modulating motor speeds, researchers have broadened the potential biomedical and environmental applications of these devices.
A study by CNIC scientists reveals metoprolol's ability to protect the heart during a heart attack is not shared by other beta-blockers. This unique property limits inflammatory damage and hyperactivation of neutrophils, which can cause significant additional injury to the heart.
Researchers at CNIC used cardiac magnetic resonance technology to measure exercise-related hypertrabeculation in a general population. A third of participants with high vigorous physical activity met the diagnostic criteria for noncompaction cardiomyopathy, despite being healthy.
Scientists at CNIC designed an algorithm that estimates cardiovascular risk in healthy middle-aged individuals based on variables like age, blood pressure, diet, and biomarkers. The EN-PESA algorithm provides a personalized risk profile for those with subclinical atherosclerosis or high short-term disease progression risk.
Researchers at CNIC have discovered a mechanism explaining how macrophages regulate obesity and related diseases like fatty liver disease and type 2 diabetes. The study shows that oxidative stress leads to mitochondrial metabolism changes in macrophages, fostering inflammation and obesity.
A study published in Cell reveals a previously unknown mechanism for the heart's waste removal, highlighting the critical role of macrophages in maintaining cardiac health. The discovery suggests that cardiac dysfunction may arise from defects in immune cells rather than cardiomyocytes.
Researchers identified mechanism of competition between distinct mitochondrial genomes in the same cell, which depends on impact on cell metabolism. The study found that factors like gene function, drugs, and dietary changes influence preference for specific mtDNA variants.
Researchers at CNIC and IIS Princesa discover that sodium ions regulate mitochondrial function, increasing reactive oxygen species production in early stages of hypoxia. This finding could lead to new treatments for diseases related to hypoxia, such as stroke and heart attack.
Researchers have identified a protein PPARα that regulates bile acid metabolism and suppresses the growth of cholangiocarcinoma in mice. The study provides new insights into liver cancer development and suggests potential therapeutic targets.
The study reveals that protein SCAF1 regulates mitochondrial energy production by optimizing the assembly of ETC complexes. In its absence, energy efficiency is reduced and physical activity capacity is impaired.
Scientists at CNIC discover a system providing cells with positional information about their location in developing organs. The study shows that malfunctioning of this system causes congenital malformations and may explain the effects of thalidomide, a drug inducing limb defects.
Researchers at CNIC have created a novel mouse model that enables the direct analysis of protein mechanical function. The model, based on titin and HaloTag-TEV genetic cassette, allows for controlled disruption of protein mechanics to study cellular responses.
Researchers at CNIC discovered a biomarker, complement component 5 (C5), that detects atherosclerosis in its preclinical phase. Plasma levels of C5 can identify individuals with subclinical atherosclerosis, helping to select those who would benefit from more costly imaging analysis.
Researchers found that 40% of asymptomatic people between 40-50 years old accumulated fatty plaques in their arteries at a rapid rate. The study shows a direct link between classical cardiovascular risk factors and disease progression.
A new study at CNIC discovers a molecular mechanism regulating macrophages, key immune sentinels. The research may lead to cancer treatments and tissue repair by targeting these cells.
Researchers at CNIC have identified an inflammatory regulatory circuit controlled by endothelial cells in the eye, which may regulate retinal vascular diseases and inflammatory disorders. The discovery provides new perspectives on treating conditions like age-related macular degeneration (AMD).
Researchers at CNIC discovered a 'disarmament' mechanism in neutrophils that reduces their toxic capacity to prevent damage to healthy tissues. This innate system, driven by CXCR2 and circadian rhythms, helps regulate the immune response and could have implications for treating conditions like myocardial infarction and stroke.
A new vasculogenic niche contributes to cardiac lymphatic system development, with cells originating from different tissues. The coronary lymphatic vessels have varied origins and functions.
Researchers at CNIC have identified molecules that act as an 'airbag' protecting cells from mechanical stress. The study shows how these molecules coordinate changes to protect the cell and prevent damage. Altering their activity could lead to new therapies for diseases related to mechanical stress.
Researchers have developed a method to monitor and predict the progression of atrial fibrillation using cardiac electrical signals from implantable devices. This technology enables personalized treatment timing, optimizing medical intervention for individual patients.
The NeutroCure project focuses on harnessing the potential of reactive oxygen species (ROS) produced by neutrophils to treat inflammatory diseases. By developing safe ROS amplifiers, the consortium aims to selectively target pathogenic inflammation and cancer cells while minimizing damage to healthy tissues.
A study published in EMBO Molecular Medicine suggests that blocking the protease MT1-MMP could protect the vasculature in the inflamed gut and reduce severity of colitis. The research found that inhibiting this protease could have potential clinical implications, including identifying biomarkers for mild IBD.
A study published in Journal of the American College of Cardiology shows that oral anticoagulant dabigatran slows Alzheimer disease progression in mice by improving cerebral circulation. The treatment reduces typical symptoms like inflammation and amyloid protein plaques.
Researchers defined the dynamics of mitochondrial DNA transfer from mothers to offspring, revealing control mechanisms to prevent heteroplasmy. The study helps devise strategies to prevent mitochondrial disease and unwanted results in medical interventions.
Researchers at CNIC discover strategies to inhibit kinase GSK3? in mice with ARVC5, reducing fibrosis and improving heart function. The study aims to translate the results to patients and investigate gene therapy strategies for potential cure.
A team of CNIC scientists identified SRSF3 as crucial for proper heart function and found that its loss leads to reduced expression of genes involved in contraction. Further research revealed that SRSF3 controls the alternative processing of mTOR, a major regulator of cell metabolism, which is essential for heart health.
A new international consensus document provides guidelines for the conduct of magnetic resonance imaging studies after a myocardial infarction. The main outcome measure recommended is absolute infarct size, with scanning timing between 3 and 7 days post-infarction.
Scientists have developed a new genetic tool called iSuRe-Cre that provides certainty in Cre-inducible genetic modifications. This innovation increases the efficiency and reliability of gene function analysis in mice, allowing for precise investigation of gene role during organ development, physiology, and disease.
Researchers at CNIC have identified a cellular and molecular mechanism that can induce productive angiogenesis in ischemic tissues. The newly discovered mechanism suggests that manipulating it could lead to optimal therapeutic angiogenesis, which may help treat cardiovascular disease.
Researchers at CNIC have discovered that the protein p38gamma plays an essential role in initiating cell division in liver cells, making it a promising therapeutic target for liver cancer. The study found that inhibiting p38gamma slows down the development of liver cancer in mice, suggesting potential treatment options.
Researchers at CNIC have discovered a hormone called adiponectin that protects the liver from liver cancer, which affects more men than women. Adiponectin is produced in higher amounts in women and slim people, with levels declining after puberty in men.
Researchers used advanced PET/MRI technology to analyze inflammatory processes in arteries of individuals with atherosclerotic plaques. The study found that inflammation is present at early stages of atherosclerosis, particularly in regions without developed plaques.